Skip to search formSkip to main contentSkip to account menu

Holoxan

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ifosfamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®)
Two forms of ifosfamide are commercially available in France: HOLOXAN® (brand‐name drug) and IFOSFAMIDE EG® (generic drug… 
2016
2016
The effects of N-acetyl-l-cysteine on the female reproductive performance and nephrotoxicity in rats
Abstract This study was designed to investigate whether the treatment with the N-acetyl-l-cysteine prior to the administration of… 
2009
2009
MRI of intimal sarcoma of the pulmonary arteries.
A 38-year-old woman presented with left lower chest pain. At the age of 3 years, a commissurotomy of the pulmonary valve and… 
2004
2004
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds
SummaryUrotoxic side effects, especially hemorrhagic cystitis, have so far been a limiting factor in the therapeutic use of… 
1999
1999
High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
UNLABELLED This study evaluates histological response, long-term outcome, and toxicity in an intensive chemotherapy program given… 
1999
1999
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération…
UNLABELLED This study evaluates histological response, long-term outcome, and toxicity in an intensive chemotherapy program given… 
1998
1998
Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).
Ifosfamide induced dominant lethal mutations in spermatozoa of mice at doses of 200 and 300 mg/kg and in spermatids and… 
1986
1986
Pharmacokinetics and bioavailability of oral ifosfamide
The bioavailability of oral N,3-bis(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (ifosfamide) (500-mg… 
1978
1978
[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
153 patients with inoperable malignant tumors were treated by the so-called synchronization therapy with vincristine and… 
1976
1976
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
In cooperative studies performed in 21 German clinics, the new cytostatic agent 3-(2-chloroethyl)-2-[(2-chloroethyl)-amino… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)